tiprankstipranks
Trending News
More News >
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL
US Market
Advertisement

Avadel Pharmaceuticals (AVDL) Ratios

Compare
755 Followers

Avadel Pharmaceuticals Ratios

AVDL's free cash flow for Q2 2025 was $0.91. For the 2025 fiscal year, AVDL's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.79 3.64 1.81 9.17 17.44
Quick Ratio
2.38 3.36 1.81 9.17 17.44
Cash Ratio
1.11 0.85 1.33 2.41 4.75
Solvency Ratio
<0.01 -2.06 -0.88 -0.45 0.06
Operating Cash Flow Ratio
0.10 -3.49 -1.26 -3.68 -3.23
Short-Term Operating Cash Flow Coverage
0.00 -137.59 -1.82 -85.90 -102.81
Net Current Asset Value
$ 62.66M$ 57.24M$ -53.09M$ 23.47M$ 114.08M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.21 0.99 0.59 0.42
Debt-to-Equity Ratio
0.03 0.40 -6.20 1.85 0.80
Debt-to-Capital Ratio
0.03 0.29 1.19 0.65 0.45
Long-Term Debt-to-Capital Ratio
0.28 0.27 1.30 0.65 0.44
Financial Leverage Ratio
2.06 1.88 -6.28 3.16 1.92
Debt Service Coverage Ratio
1.70 -13.74 -2.43 -6.36 -1.70
Interest Coverage Ratio
0.40 -13.94 -7.99 -8.60 -2.82
Debt to Market Cap
0.02 0.03 0.30 0.30 0.36
Interest Debt Per Share
0.09 0.56 2.39 2.65 2.71
Net Debt to EBITDA
-9.14 -0.03 -0.58 -1.11 -1.68
Profitability Margins
Gross Profit Margin
89.64%96.97%0.00%0.00%74.29%
EBIT Margin
1.93%-539.61%0.00%0.00%35.43%
EBITDA Margin
3.00%-533.29%0.00%0.00%-156.58%
Operating Profit Margin
1.02%-492.97%0.00%0.00%-164.15%
Pretax Profit Margin
-2.64%-574.96%0.00%0.00%-22.75%
Net Profit Margin
-1.32%-573.17%0.00%0.00%31.47%
Continuous Operations Profit Margin
-1.32%-573.17%0.00%0.00%31.47%
Net Income Per EBT
49.99%99.69%123.35%83.02%-138.29%
EBT Per EBIT
-258.83%116.63%113.07%108.88%13.86%
Return on Assets (ROA)
-1.56%-97.32%-103.52%-31.27%2.26%
Return on Equity (ROE)
-3.73%-182.67%650.10%-98.83%4.33%
Return on Capital Employed (ROCE)
1.74%-107.83%-128.01%-37.81%-12.36%
Return on Invested Capital (ROIC)
0.86%-105.94%-104.29%-31.14%17.04%
Return on Tangible Assets
-1.72%-108.40%-118.56%-33.56%2.38%
Earnings Yield
-0.20%-14.16%-31.95%-16.35%1.99%
Efficiency Ratios
Receivables Turnover
5.44 2.08 0.00 0.00 6.71
Payables Turnover
2.27 0.07 0.19 0.11 1.96
Inventory Turnover
0.98 0.08 0.00 0.00 0.00
Fixed Asset Turnover
20.08 2.14 0.00 0.00 7.54
Asset Turnover
1.18 0.17 0.00 0.00 0.07
Working Capital Turnover Ratio
2.32 0.39 0.00 0.00 0.15
Cash Conversion Cycle
280.09 -279.07 -1.93K -3.44K -132.15
Days of Sales Outstanding
67.08 175.24 0.00 0.00 54.36
Days of Inventory Outstanding
374.14 4.48K 0.00 0.00 0.00
Days of Payables Outstanding
161.14 4.93K 1.93K 3.44K 186.50
Operating Cycle
441.23 4.65K 0.00 0.00 54.36
Cash Flow Ratios
Operating Cash Flow Per Share
0.06 -1.60 -1.17 -1.32 -0.92
Free Cash Flow Per Share
0.05 -1.60 -1.18 -1.32 -0.92
CapEx Per Share
<0.01 0.00 0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.97 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
30.10 0.00 -98.19 -2.97K -497.29
Capital Expenditure Coverage Ratio
30.10 0.00 -98.19 -2.97K -497.29
Operating Cash Flow Coverage Ratio
2.00 -3.63 -0.54 -0.53 -0.37
Operating Cash Flow to Sales Ratio
0.02 -4.60 0.00 0.00 -2.18
Free Cash Flow Yield
0.37%-11.35%-16.51%-16.35%-13.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-488.43 -7.06 -3.13 -6.12 50.37
Price-to-Sales (P/S) Ratio
6.44 40.48 0.00 0.00 15.85
Price-to-Book (P/B) Ratio
15.74 12.90 -20.35 6.04 2.18
Price-to-Free Cash Flow (P/FCF) Ratio
270.42 -8.81 -6.06 -6.12 -7.25
Price-to-Operating Cash Flow Ratio
262.06 -8.81 -6.12 -6.12 -7.26
Price-to-Earnings Growth (PEG) Ratio
-5.51 0.56 -0.04 <0.01 -0.44
Price-to-Fair Value
15.74 12.90 -20.35 6.04 2.18
Enterprise Value Multiple
205.30 -7.62 -4.99 -6.69 -11.80
Enterprise Value
1.36B 1.14B 487.31M 567.26M 412.82M
EV to EBITDA
205.30 -7.62 -4.99 -6.69 -11.80
EV to Sales
6.17 40.63 0.00 0.00 18.48
EV to Free Cash Flow
258.90 -8.84 -6.86 -7.33 -8.45
EV to Operating Cash Flow
250.30 -8.84 -6.93 -7.34 -8.47
Tangible Book Value Per Share
0.76 0.88 -0.63 1.05 2.74
Shareholders’ Equity Per Share
0.94 1.09 -0.35 1.34 3.06
Tax and Other Ratios
Effective Tax Rate
0.50 <0.01 -0.23 0.17 2.38
Revenue Per Share
2.29 0.35 0.00 0.00 0.42
Net Income Per Share
-0.03 -2.00 -2.29 -1.32 0.13
Tax Burden
0.50 1.00 1.23 0.83 -1.38
Interest Burden
-1.37 1.07 1.12 1.12 -0.64
Research & Development to Revenue
0.08 0.47 0.00 0.00 0.92
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.09 0.57 0.00 0.00 0.13
Income Quality
-1.86 0.80 0.51 1.00 -6.93
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis